
Renal Cell Carcinoma (RCC) is kidney cancer, which starts in the cells of the kidneys filtering waste materials and excessive fluids from the blood. RCC is an adult kidney cancer.
Causes
Risk Factors:
The medical treatment of carcinoid tumours in India has adopted the newest research and technologies to meet worldwide clinical standards and healthcare capabilities.
The medical treatment for Renal Cell Carcinoma (RCC) requires evaluating the patient's severity and medical condition. The following are the treatment options:
Surgery: Two main surgical procedures exist for renal cell carcinoma (RCC): radical nephrectomy, which means excision of the entire kidney, and partial nephrectomy, which consists of tumour excision with some conservation of kidney function. The best outcomes for localised RCC are related to surgery.
Targeted therapy : Agents that inhibit some biological pathways critical for tumour development are generally indicated when the disease is in more advanced stages or surgery has not yet been an option.
Cost Start From USD 8000 - USD 12000Explore Options
Immunotherapy : Checkpoint inhibitors enhance the immune response against the tumour cells so that they may be indicated for advanced or metastatic RCC, usually combined with targeted therapy.
Cost Start From USD 3000 - USD 5000Explore Options
Radiation therapy: Radiation helps shrink tumours, palliate symptoms like pain, or treat other organ metastases such as bone or lung. It is not a first-line treatment but can also be employed for pain management.
Ablation and chemotherapy : Ablation therapies, such as RFA or cryoablation, may be done for small tumours as minimally invasive procedures in patients unfit for surgery; chemotherapy is not commonly used in renal cell carcinoma but may apply in certain histologic types or after other treatments have failed.
Cost Start From USD 600 - USD 700Explore Options
These are the standard diagnostic methods for diagnosing Renal Cell Carcinoma (RCC):
MediRehab (chain of Rehab centres - part of MediGence provides comprehensive rehabilitation services designed to support patients in India. Additional services are as per the patient's requirement. These services include:
Renal Cell Carcinoma (RCC), a targeted therapy-dependent malignancy, can block cancer growth pathways, and immunotherapies can boost the immune system's capability to fight cancer. Chemotherapy is not so much a treatment option for RCC. Therapy is determined, mainly focusing on cancer stage, rate of progression, and patient response to prior treatment.









Pune, India
Ruby Hall Clinic located in Pune, India is accredited by NABH. Also listed below are some of the most prominent infrastructural details:

Hyderabad, India
Yashoda Hospital, Malakpet located in Hyderabad, India is accredited by NABH, NABL. Also listed below are some of the most prominent infrastructural details:

Ghaziabad, India
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
The following are the growing reasons for India being frequented for Renal Cell Carcinoma (RCC) treatment:
If detected early and treated surgically, RCC is curable, whereas treatment of late or metastatic RCC is much more difficult since a cure may not always be achieved; therefore, the main goal of treatment will be disease management and improvement in quality of life.
The survival rates for RCC vary according to the stage at diagnosis. Localised RCC has a 5-year survival rate greater than 90%, while the rate drops significantly for metastatic RCC; however, therapies are improving pediatric outcomes.
There are no guaranteed ways to prevent RCC, but reducing risk factors like cessation of smoking, maintaining a healthy body weight, and controlling blood pressure may help decrease the chances of developing the disease.
Side effects of treatment strategies for RCC include surgery, immunotherapy, and targeted therapies; fatigue, nausea, skin rashes, high blood pressure, and increased susceptibility to infections are among them. Discussions with healthcare team members regarding potential side effects can facilitate effective management.
Yes, RCC can still recur even after successful treatment. Continuous monitoring with regular check-ups and imaging tests is necessary to catch any disease recurrence in its early stage so that measures can be taken accordingly.
The survival rate for RCC in India is stage-dependent at the time of diagnosis. For localised RCC, five-year survival can be very high (up to 80-90%). Survival rates, however, drop sharply for advanced or metastatic RCC. If detected and treated early, the prognosis is better.
A healthy diet during treatment for RCC is essential. Most hospitals in India provide dietary counselling for all patients to improve their health, maintain their weight, and support kidney function. Dietary recommendations often include a low-sodium, nutrient-rich diet and good hydration.
Post-treatment follow-up visits are scheduled for every 3 to 6 months for the next few years, depending on the stage of the cancer and involve regular imaging (CT scan or MRI) and blood tests for monitoring recurrence or metastasis.
Patients receiving treatment for RCC should ideally follow a healthy lifestyle, stay active, hydrate well, and refrain from smoking or excessive alcohol intake. Stress-relieving techniques and practising mindfulness will further improve well-being.